Carole Nuechterlein is an Investor at Roche, whose known portfolio counts 14 companies.
Is Carole Nuechterlein a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
Investor at Roche, whose known portfolio counts 14 companies
- Freenome
- C4 Therapeutics
- Splice Bio
- GlycoEra
- Flatiron Health
- MISSION Therapeutics
- NMD Pharma
- Cour Pharmaceuticals Development
- Proacta
- Affimed
- DiogenX
- Mironid
- and 2 more
Investor Profile
Carole Nuechterlein is listed against sectors AI and Healthcare, and focus areas Biotech, Data Analytics, Diagnostics and Digital Health in the database.
Roche appears in Growth, Late-Stage and Pre-Seed rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Carole Nuechterlein is worth approaching.
Colleagues at Roche
David Krummenacher
Investor
Lucerne, Switzerland
Deborah Weyih
Investor
Rodersdorf, Switzerland
Ouali Omani
Global Commercialisation Strategy Leader
Basel, Switzerland
Muriel Badawi
Affiliated
Paris, France
David Evans
Senior Investment Director
Basel, Switzerland
Ursula Erasmus
Investor
Canada
Cedric Mauchien
Investor
Zürich, Switzerland
Jacques Mizrahi
Executive Leader, Cardiovascular & Metabolic Diseases
Basel, Switzerland
Frequently asked questions
Who is Carole Nuechterlein?
Carole Nuechterlein is a corporate venture investor based in Basel, Switzerland, listed as Investor at Roche. The known portfolio of that firm counts 14 companies. That portfolio belongs to the firm, not to Carole Nuechterlein personally.
What does Carole Nuechterlein invest in?
Listed sectors include AI and Healthcare; listed focus areas include Biotech, Data Analytics, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Carole Nuechterlein invest at?
Roche appears in Growth, Late-Stage and Pre-Seed rounds across its known deals, and Carole Nuechterlein is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Carole Nuechterlein listed at?
Carole Nuechterlein is listed as Investor at Roche. 8 other people in the database share a firm with Carole Nuechterlein.
How do I contact Carole Nuechterlein?
A phone number and a LinkedIn page are on file for Carole Nuechterlein. They are readable inside RaiseHunt after you create an account. The database holds no email address for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal